Pharmaceuticals What does it take to be an “active ingredient”?CJEU called upon to rule on Articles 1(b) and 3(a) for Halozyme’s SPC application for Herceptin SC (C-456/24)Read More 21Aug2024 Major win for Sanofi and Regeneron in the UPC’s first revocation action (UPC_CFI_1/2023)Carpmaels & Ransford leads the winning team in first ever UPC revocation decision of the Central Division UPCRead More 16Jul2024 Questions on claim interpretation referred to Enlarged Board of Appeal of the EPOGuidance sought on divergence in case law in new case G1/24Read More 01Jul2024 The European Parliament approves reforms to the EU’s rules for medicinesEuropean Parliament has now approved amended pharmaceutical reform legislation, clearing the first hurdle in the legislative processRead More 25Jun2024 The UPC – one year inA strong start from the new Court in its first 12 months and many more milestones to comeRead More 31May2024 Changing languages at the UPCUPC Court of Appeal issues the first decision on Article 49(5) UPCARead More 19Apr2024 Data-driven drug development: applied AIThe EPO’s requirements for sufficiency in applied AI and machine learning inventionsRead More 21Mar2024 Could the UK’s Court of Appeal bring back SPCs for new medical indications?The UKIPO’s refusal of Merck Serono’s UK SPC application for a new medical indication of cladribine has been upheld by the High Court but is set to reach the Court of AppealRead More 21Feb2024 Data-driven drug development: in silico dataUsing data derived from AI to support life sciences patentsRead More 16Nov2023 Enlarged Board of Appeal delivers decisions on formal priority entitlementThe EPO Enlarged Board of Appeal has held that the applicant benefits from a rebuttable presumption under the EPC that the applicant claiming priority is entitled to claim priorityRead More 10Oct2023<12345…9> Type Firm News Insights PodcastsServiceProtectDealDisputeUPCSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026JulyJuneMayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
